Cargando…

Association between common cardiovascular drugs and depression

OBJECTIVE: Cardiovascular diseases are associated with an increased risk of depression, but it remains unclear whether treatment with cardiovascular agents decreases or increases this risk. The effects of drugs on individual usage are also often unknown. This review aimed to examine the correlation...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Shu-Hui, Ren, Xue-Qun, Zhang, Li-Jun, Liu, Mei-Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631412/
https://www.ncbi.nlm.nih.gov/pubmed/34759230
http://dx.doi.org/10.1097/CM9.0000000000001875
_version_ 1784607556424957952
author Tao, Shu-Hui
Ren, Xue-Qun
Zhang, Li-Jun
Liu, Mei-Yan
author_facet Tao, Shu-Hui
Ren, Xue-Qun
Zhang, Li-Jun
Liu, Mei-Yan
author_sort Tao, Shu-Hui
collection PubMed
description OBJECTIVE: Cardiovascular diseases are associated with an increased risk of depression, but it remains unclear whether treatment with cardiovascular agents decreases or increases this risk. The effects of drugs on individual usage are also often unknown. This review aimed to examine the correlation between depression and common cardiovascular drugs, develop more potent interventions for depression in cardiovascular patients, and further research on the bio-behavioural mechanisms linking cardiovascular drugs to depression. DATA SOURCES: The data in this review were obtained from articles included in PubMed, EMBASE, and Web of Science. STUDY SELECTION: Clinical trials, observational studies, review literature, and guidelines about depression and cardiovascular drugs were selected for the article. RESULTS: We systematically investigated whether the seven most used cardiovascular drugs were associated with altered risk of incident depression in this literature review. Statins have been proven to have antidepressant effects. Some studies believe angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor blocker (ARB) can exert an antidepressant influence by acting on the renin-angiotensin system, but further clinical trials are needed to confirm this. Beta-blockers have previously been associated with depression, but the current study found no significant association between beta blockers and the risk of depression. Aspirin may have antidepressant effects by suppressing the immune response, but its role as an antidepressant remains controversial. calcium channel blockers (CCBs) can regulate nerve signal transduction by adjusting calcium channels, but whether this effect is beneficial or harmful to depression remains unclear. Finally, some cases have reported that nitrates and diuretics are associated with depression, but the current clinical evidence is insufficient. CONCLUSIONS: Statins have been proven to have antidepressant effect, and the antidepressant effects of ACEIs/ARB and aspirin are still controversial. CCBs are associated with depression, but it is unclear whether it is beneficial or harmful. No association has been found with β-blockers, diuretics, and nitrates.
format Online
Article
Text
id pubmed-8631412
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-86314122021-12-01 Association between common cardiovascular drugs and depression Tao, Shu-Hui Ren, Xue-Qun Zhang, Li-Jun Liu, Mei-Yan Chin Med J (Engl) Systematic Review OBJECTIVE: Cardiovascular diseases are associated with an increased risk of depression, but it remains unclear whether treatment with cardiovascular agents decreases or increases this risk. The effects of drugs on individual usage are also often unknown. This review aimed to examine the correlation between depression and common cardiovascular drugs, develop more potent interventions for depression in cardiovascular patients, and further research on the bio-behavioural mechanisms linking cardiovascular drugs to depression. DATA SOURCES: The data in this review were obtained from articles included in PubMed, EMBASE, and Web of Science. STUDY SELECTION: Clinical trials, observational studies, review literature, and guidelines about depression and cardiovascular drugs were selected for the article. RESULTS: We systematically investigated whether the seven most used cardiovascular drugs were associated with altered risk of incident depression in this literature review. Statins have been proven to have antidepressant effects. Some studies believe angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor blocker (ARB) can exert an antidepressant influence by acting on the renin-angiotensin system, but further clinical trials are needed to confirm this. Beta-blockers have previously been associated with depression, but the current study found no significant association between beta blockers and the risk of depression. Aspirin may have antidepressant effects by suppressing the immune response, but its role as an antidepressant remains controversial. calcium channel blockers (CCBs) can regulate nerve signal transduction by adjusting calcium channels, but whether this effect is beneficial or harmful to depression remains unclear. Finally, some cases have reported that nitrates and diuretics are associated with depression, but the current clinical evidence is insufficient. CONCLUSIONS: Statins have been proven to have antidepressant effect, and the antidepressant effects of ACEIs/ARB and aspirin are still controversial. CCBs are associated with depression, but it is unclear whether it is beneficial or harmful. No association has been found with β-blockers, diuretics, and nitrates. Lippincott Williams & Wilkins 2021-11-20 2021-11-10 /pmc/articles/PMC8631412/ /pubmed/34759230 http://dx.doi.org/10.1097/CM9.0000000000001875 Text en Copyright © 2021 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Systematic Review
Tao, Shu-Hui
Ren, Xue-Qun
Zhang, Li-Jun
Liu, Mei-Yan
Association between common cardiovascular drugs and depression
title Association between common cardiovascular drugs and depression
title_full Association between common cardiovascular drugs and depression
title_fullStr Association between common cardiovascular drugs and depression
title_full_unstemmed Association between common cardiovascular drugs and depression
title_short Association between common cardiovascular drugs and depression
title_sort association between common cardiovascular drugs and depression
topic Systematic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631412/
https://www.ncbi.nlm.nih.gov/pubmed/34759230
http://dx.doi.org/10.1097/CM9.0000000000001875
work_keys_str_mv AT taoshuhui associationbetweencommoncardiovasculardrugsanddepression
AT renxuequn associationbetweencommoncardiovasculardrugsanddepression
AT zhanglijun associationbetweencommoncardiovasculardrugsanddepression
AT liumeiyan associationbetweencommoncardiovasculardrugsanddepression